Deerfield Management’s ARS Pharmaceuticals SPRY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$60.3M	Hold	7,503,812	–	–	0.71%	42
2025 Q4	$87.4M	Hold	7,503,812	–	–	1.12%	26
2025 Q3	$75.4M	Sell	7,503,812 -2,220,696	-23%	-$31.9M	1.15%	27
2025 Q2	$170M	Sell	9,724,508 -790,149	-8%	-$11.4M	3.08%	7
2025 Q1	$132M	Hold	10,514,657	–	–	2.61%	8
2024 Q4	$111M	Sell	10,514,657 -563,270	-5%	-$7.89M	2.1%	12
2024 Q3	$161M	Hold	11,077,927	–	–	2.4%	7
2024 Q2	$94.3M	Hold	11,077,927	–	–	1.57%	20
2024 Q1	$113M	Hold	11,077,927	–	–	1.97%	16
2023 Q4	$60.7M	Hold	11,077,927	–	–	1.12%	27
2023 Q3	$41.9M	Hold	11,077,927	–	–	0.92%	29
2023 Q2	$74.2M	Hold	11,077,927	–	–	1.58%	19
2023 Q1	$72.1M	Hold	11,077,927	–	–	1.61%	19
2022 Q4	$94.5M	Buy	+11,077,927	New	+$71.9M	1.96%	18